Last reviewed · How we verify
Chronic schizophrenia
Approved treatments
- Carphenazin
- Barhemsys · Acacia
Barhemsys works by blocking dopamine receptors in the brain. - Haldol · Johnson & Johnson (Janssen)
- Haldol · Johnson & Johnson
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic schizophrenia patent landscape — cliff calendar, originator estates, attackable patents
- Chronic schizophrenia treatment landscape brief
- Chronic schizophrenia treatment updates RSS
Frequently asked questions about Chronic schizophrenia
What drugs treat Chronic schizophrenia?
Tracked treatments include Carphenazin, Barhemsys, Haldol.
What is the treatment for Chronic schizophrenia?
Standard treatment for Chronic schizophrenia includes Carphenazin, Barhemsys, Haldol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic schizophrenia patent cliff · Chronic schizophrenia CI report
- Treatment: Carphenazin
- Treatment: Barhemsys · Acacia
- Treatment: Haldol · Johnson & Johnson (Janssen)
- Treatment: Haldol · Johnson & Johnson
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing